John L. Cameron

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Incidental Diagnosis of Pancreatic Cancer and Association with Improved Patient Outcomes: Assessing the Potential Clinical Use of Liquid Biopsy-Based Screening Tests

  Journal of the American College of Surgeons · 2025-12-09

• Management and outcomes for portal venous thrombosis after pancreaticoduodenectomy

  Journal of Gastrointestinal Surgery · 2025-08-25

• Pancreatic and Peripancreatic Neural Crest–Derived Tumors: An Updated Contemporary Single Center Experience

  Pancreas · 2025-08-20

• The impact of perioperative chemotherapy in patients with pancreatic adenosquamous carcinoma

  Surgery · 2025-08-13

• ADVANCES IN Surgery

  Advances in Surgery · 2025-08-05

• The Mutational Status of Driver Genes in Patients With Resected Pancreatic Ductal Adenocarcinoma Is Associated With Pathological Characteristics and Overall Survival

  Annals of Surgery · 2025-06-18 · 4 citations

• ASO Visual Abstract: Association Between Adjuvant Therapy and Survival in Resected Pancreatic Ductal Adenocarcinoma After Different Types and Durations of Neoadjuvant Therapy

  Annals of Surgical Oncology · 2025-06-04

• Association Between Adjuvant Therapy and Survival in Resected Pancreatic Ductal Adenocarcinoma After Different Types and Durations of Neoadjuvant Therapy

  Annals of Surgical Oncology · 2025-05-29 · 3 citations

• Prognostic Features in Surgically Resected Well-Differentiated Pancreatic Neuroendocrine Tumors: An Analysis of 904 Patients with 7882 Person-Years of Follow-UpPreprint

  medRxiv · 2025-04-03

• Ductal Cancerization at the Pancreatic Neck Margin

  Annals of Surgery · 2025-03-27

• 1626 Pathologic Evaluation of a Clinically Well-Characterized Series of Well-Differentiated Pancreatic Neuroendocrine Tumors Surgically Resected from 889 Patients with 7824 person-years of Follow-up Supports the Sub-Division of Grade 2 Neoplasms Based on Ki-67 Labeling

  Laboratory Investigation · 2025-03-01

• Phase 1 Study of Adjuvant Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Transduced Pancreatic Tumor Cell Vaccine, Low-Dose Cyclophosphamide, and Stereotactic Body Radiation Therapy Followed by FOLFIRINOX in High-Risk Resected Pancreatic Ductal Adenocarcinoma

  International Journal of Radiation Oncology*Biology*Physics · 2024-11-14 · 7 citations

• Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcinoma

  Annals of Surgery · 2024-09-04 · 5 citations

• ADVANCES IN Surgery

  Advances in Surgery · 2024-07-31